Mathematical Modeling, Analysis, and Simulation to Accelerate and De-risk Therapeutic R&D

Fit-for-purpose model

"Applied BioMath’s modeling approach will be an important predictor of optimal dosing regimens to support potential future registration clinical trials for our targeted product candidates."
James F. Oliviero - Checkpoint Therapeutics



Partner Companies


NIH and FDA Grant Funding

Many reasons to choose Applied BioMath

Learn About Us >>

What Our Scientific Partners Are Saying

Working with Applied BioMath enabled us to foresee any hurdles we may have encountered and also ensured we are structuring our trials such that we are targeting the right patients and the right doses.

Mark Currie, PhD
Ironwood Pharmaceuticals

We chose to work with Applied BioMath because of their significant expertise and strength in developing mechanistic QSP models in oncology.

Karim Azer, PhD

Applied BioMath delivered exactly what we asked for in the time frame agreed upfront. Josh and John worked with the team to leverage both internal and external information and develop a fit-for-purpose model in an eight-week time frame. 

Anne Heatherington, PhD